Brind.

Wave Life Sciences, based in Singapore, is developing therapies for DMD and targeting Huntington’s disease.

1 report, 1 independent Updated Aug 29

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Wave Life Sciences DMD Singapore

Keep exploring

The entities involved

Wave Life Sciences
biotechnology company
- Regeneron Pharmaceuticals and Wave Life Sciences are being compared as healthcare companies.Sun 14:10
- Wave Life Sciences is developing WVE-007, an investigational GalNAc-siRNA product, for MASH indications.Wed 12:44
DMD
Nothing else this week.
Singapore
sovereign island country and city-state in maritime Southeast Asia
- The Parliamentary Budget Officer notes that separating capital expenditure (capex) and operational expenditure (opex) is a common practice.Mon 17:41
- Bird species typically found in Java.Mon 17:13

Related events

A series of business development initiatives launched on June 25, 2026, targeting various international markets including Europe, Mexico, and Singapore.Jun 28

Coverage

Newest first; wire copies grouped

Aug 29Insider MonkeyWave Life Sciences Ltd. (WVE) Gains Momentum With Multiple RNA Wins We recently published 10 Best Biotech Stocks to Buy Under $10. Wave Life Sciences Ltd. stands second among them. Wave Life Sciences